Compounds and methods for inducing apoptosis in proliferating cells
OwnerChing-Shih Chen, Xueqin Song +1inventors
InventorsChing-Shih Chen, Xueqin Song, Ho-Pi Lin
Life of this patent
Estimating the term…
Loading patent…
OwnerChing-Shih Chen, Xueqin Song +1inventors
InventorsChing-Shih Chen, Xueqin Song, Ho-Pi Lin
Estimating the term…
Compounds useful for inducing apoptosis in proliferative cells, particularly cancer cells, including but not limited to prostate cancer, leukemia, non-small cell lung cancer, colon cancer, CNS cancer, melanoma, ovarian cancer, renal cancer, bladder cancer, lymphoma, and breast cancer. These compounds are particularly useful in the treatment of androgen-independent cancers, including hormone-refractory prostate cancer. Further provided are methods of treating cancer in a subject in need of such treatment using the compounds of the present invention. Further provided are methods for using the compounds of the present invention to treat, inhibit, or delay the onset of cancer in a subject. Further provided are methods of inducing apoptosis in rapidly proliferating cells, particularly, though not necessarily cancer cells, using the compounds of the present invention.
A method of treating, inhibiting, or delaying the onset of a cancer in a subject in need of treatment, the method comprising administering a therapeutically effective amount of a compound of formula I:
A method of inducing apoptosis in rapidly proliferating cells, said method comprising introducing a pharmacologically effective amount of the compound of formula I:
A method of treating, inhibiting, or delaying the onset of cancer in a subject in need of treatment, the method comprising administering a therapeutically effective amount of a compound having formula I:
A method of inducing apoptosis in rapidly proliferating cells, the method comprising introducing a therapeutically effective amount of the compound of formula II:
A method for treating, inhibiting, or delaying the onset of a cancer in a subject in need of such treatment, wherein the cancer is selected from the group consisting of leukemia, non-small cell lung cancer, colon cancer, CNS cancer, melanoma, ovarian cancer, renal cancer, prostate cancer, bladder cancer, lymphoma, and breast cancer;
A method of using 4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide for the treatment of prostate cancer, the method comprising introducing a therapeutically effective amount of 4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide or a pharmaceutically acceptable salt thereof to a subject in need of such treatment.
Dependencies are inferred from the claim text.